Tandem Labs
Donna Zormeier has extensive experience in the field of bioanalytical testing and chemistry. Currently serving as an Associate QA Coordinator at Tandem Labs since March 2011, Zormeier conducts GLP phase inspections. Prior to this role, Zormeier worked at Gilead Sciences, Inc. as a Sr. Research Associate II from November 2002 to August 2010, where responsibilities included managing small molecule quantitative bioanalytical analysis and evaluating sample preparation techniques. Earlier in the career, Zormeier was a Research Chemist II at BASF Corporation from 1990 to August 2002, focusing on herbicide and fungicide formulation, and worked as a Product Development Chemist at Noxell Corporation from 1985 to 1989, developing skin care products. Zormeier holds a Bachelor’s degree in Biology and Business Management from St. Cloud State University, awarded in 1977.
This person is not in any offices
Tandem Labs
Tandem Labs (now Covance) is a leading bioanalytical service provider with cutting-edge technology and services focused on supporting small and large-molecule development efforts for discovery, pre-clinical and clinical studies. We strive to differentiate ourselves with our scientific expertise, responsive project management staff, structured method development, on-time metrics, and strong regulatory history. Our goal is to use our experience to make your job easier and to shorten your development timelines. Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading health care diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. Going forward, Tandem Labs and Covance will operate together under the Covance brand. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue in excess of $8 billion in 2013 and more than 48,000 employees in over 60 countries, LabCorp offers innovative solutions to healthcare stakeholders. LabCorp clients include physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. To learn more about Covance Drug Development, visit www.covance.com.